Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.789996
Title: Dysregulation of the cell cycle in breast cancer
Author: Loddo, M.
ISNI:       0000 0004 8502 8925
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Dysregulation of the cell cycle underlies the uncontrolled cell proliferation that characterises cancer. The cell cycle machinery can be regarded as a final and critical step in growth control downstream of complex and redundant oncogenic signalling networks and therefore a potentially attractive intervention point for cancer diagnostics and therapeutics. In the work of this thesis I investigated dysregulation of the cell cycle engine in breast cancer aimed at identification of new prognosticators and therapeutic targets. I conducted an analysis of the DNA replication machinery (G1/S regulators) and the mitotic engine proteins (G2/M regulators) in a cohort of invasive breast cancers. I was able to demonstrate that these critical regulators of the cell division cycle, namely Mcm2, geminin, Aurora A, Plk1 and H3S10ph are powerful independent prognosticators of disease progression. Notably multiparameter analysis of these core G1/S and G2/M regulators revealed that breast cancer resides in three distinct cell cycle states and that these phenotypes impact on prognosis and also predict response to S- and M-phase directed chemotherapies. This cell cycle analysis also revealed a profound mitotic perturbation in breast cancer, namely a prophase/prometaphase delay. This tumour specific mitotic phenotype was compared with the mitotic phenotypes generated in the MitoCheck screen (www.mitocheck.org), a genomewide RNAi screen performed in HeLa cells, aimed at the identification of genes involved in the process of cell division. This led to the identification of pregnancy associated plasma protein A (PAPPA) gene as a new candidate tumour suppressor in breast cancer. Intriguingly I was able to show that PAPPA functions as an evolutionary conserved regulator of mitosis in mammalian cells, is epigenetically silenced in early multi step breast tumourigenesis, and has potential as a prognosticator in mammography detected disease.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.789996  DOI: Not available
Share: